Cara Therapeutics Announces Presentations at Kidney Week 2019

Posted by Invest In Weed | Nov 1, 2019 | Biomedical, Conferences, US Stocks | 0

Late-breaking oral presentation to highlight data from KALM-1 pivotal Phase 3 trial of KORSUVA™ Injection in hemodialysis patients with pruritus.

Leave a Reply

Invest In Weed TV

GET LISTED

Invest In Weed - Get Listed, List your business

News Highlights

Silly Mistakes to Avoid When Purchasing Cannabis Equipment July 17, 2020
Stages of the Cannabis Plant Growth Cycle December 3, 2019
Future Farm Prepares Maine-Grown Hemp Biomass and Seeds for Processing and Market November 25, 2019
Auxly Announces Outdoor Cultivation Expansion Through the Launch of Robinsons Outdoor Grow November 18, 2019
Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram November 11, 2019
Future Farm’s Maine Hemp Harvest Nearing Completion October 31, 2019
Massive Revenues Expected as Hemp, Inc. Updates Shareholders on the First Phase of Processing its Hemp Harvest in Oregon October 25, 2019
KALY – Kali-Extracts Publishes Photos From Historic First Legal Hemp Harvest October 18, 2019

Join Our Newsletter

Get stock alerts, news & related alerts straight to your inbox!